 REDWOOD CITY, CA ACCESSWIRE April 8, 2021 Avinger, Inc. NASDAQ:AVGR, a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease PAD, today provided an update on the commercial launch of Tigereye CTO Crossing catheters for the treatment of PAD. Following limited launch in the fourth quarter of 2020, Avinger initiated full commercial launch of Tigereye in January 2021. 